These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11159931)

  • 21. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia.
    Ho BC; Alicata D; Ward J; Moser DJ; O'Leary DS; Arndt S; Andreasen NC
    Am J Psychiatry; 2003 Jan; 160(1):142-8. PubMed ID: 12505813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prodromal stage of psychotic illness: observation, detection or intervention?
    Addington J
    J Psychiatry Neurosci; 2003 Mar; 28(2):93-7. PubMed ID: 12670126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive course in first-episode psychosis and clinical correlates: A 4 year longitudinal study using the MATRICS Consensus Cognitive Battery.
    Kenney J; Anderson-Schmidt H; Scanlon C; Arndt S; Scherz E; McInerney S; McFarland J; Byrne F; Ahmed M; Donohoe G; Hallahan B; McDonald C; Cannon DM
    Schizophr Res; 2015 Dec; 169(1-3):101-108. PubMed ID: 26416442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosis of Alzheimer disease: validity of the construct and response to risperidone.
    Schneider LS; Katz IR; Park S; Napolitano J; Martinez RA; Azen SP
    Am J Geriatr Psychiatry; 2003; 11(4):414-25. PubMed ID: 12837670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
    Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
    Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between cognitive functioning and occupational status in persons with a recent onset of psychosis.
    Dickerson FB; Stallings C; Origoni A; Boronow JJ; Sullens A; Yolken R
    J Nerv Ment Dis; 2007 Jul; 195(7):566-71. PubMed ID: 17632246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does treatment delay predict occupational functioning in first-episode psychosis?
    Norman RM; Mallal AK; Manchanda R; Windell D; Harricharan R; Takhar J; Northcott S
    Schizophr Res; 2007 Mar; 91(1-3):259-62. PubMed ID: 17291725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity.
    Gladsjo JA; McAdams LA; Palmer BW; Moore DJ; Jeste DV; Heaton RK
    Schizophr Bull; 2004; 30(4):739-54. PubMed ID: 15957196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.
    Aarsland D; Larsen JP; Lim NG; Tandberg E
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):392-4. PubMed ID: 10440017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Duration of untreated psychosis in first-episode schizophrenia: clinical and cognitive correlates].
    Galińska B; Szulc A; Czernikiewicz A
    Psychiatr Pol; 2005; 39(5):859-68. PubMed ID: 16358587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic strategies in the first psychotic episode].
    Douki S; Taktak MJ; Ben Zineb S; Cheour M
    Encephale; 1999 Nov; 25 Spec No 3():44-51. PubMed ID: 10598294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
    Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
    Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cognitive changes in response to antipsychotic medication: design and interpretation problems].
    Gonzalez-Blanch C
    Actas Esp Psiquiatr; 2008; 36(4):244-5; author reply 245-6. PubMed ID: 18780424
    [No Abstract]   [Full Text] [Related]  

  • 35. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication.
    Peralta V; Campos MS; de Jalon EG; Cuesta MJ
    Schizophr Res; 2010 May; 118(1-3):168-75. PubMed ID: 20071147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximizing function after first-episode psychosis.
    Kopala LC
    CNS Spectr; 2004 Oct; 9(10 Suppl 11):34-9. PubMed ID: 15475875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ; Rabinowitz J
    Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight in first-episode psychosis.
    McEvoy JP; Johnson J; Perkins D; Lieberman JA; Hamer RM; Keefe RS; Tohen M; Glick ID; Sharma T
    Psychol Med; 2006 Oct; 36(10):1385-93. PubMed ID: 16740175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study.
    Ritsner MS; Miodownik C; Ratner Y; Shleifer T; Mar M; Pintov L; Lerner V
    J Clin Psychiatry; 2011 Jan; 72(1):34-42. PubMed ID: 21208586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [First-episode psychosis, cognitive difficulties and remediation].
    Vidailhet P
    Encephale; 2013 Sep; 39 Suppl 2():S83-92. PubMed ID: 24084427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.